Dr Joshua Chai

Accolades: President’s Prize of the Royal Society of Medicine (Lipids, Metabolism & Vascular Risk section), London, UK (2016) Finalist award for American Heart Association Melvin Judkins Young Clinical Investigators , Florida, USA (2015) Young Investigator Award - European Atherosclerosis Society, Glasgow, UK (2015) Fellow of the Cambridge Commonwealth Society , University of Cambridge (2004 and 2000) Rolleston Scholar of St John's College, University of Cambridge (2001) Qualifications: BA  (Natural Sciences - Neurobiology),  University of Cambridge , 2002 MB BChir ,  University of Cambridge , 2004 MA ,  University of Cambridge , 2006 MRCP , R oyal College of Physicians (London),  2008 DPhil (PhD)  in Cardiovascular Medicine,  University of Oxford , 2016 CCT in Cardiology (Intervention) ,  London Deanery Post-CCT Complex Interventional Fellowship ,  Bournemouth, UK Elected  Fellow of the Royal College of Physicians (FRCP) , 2020 Dr Chai is an internationally award-winning Consultant Cardiologist at Wexham Park Hospital in South Buckinghamshire / East Berkshire, and Honorary Consultant Cardiologist at the Royal Brompton Hospital in London. He grew up in Hong Kong and was educated at Eton College as an Oppidan Scholar. He studied medicine at University of Cambridge, and was elected Rolleston Scholar of St John's College (University of Cambridge), where he completed his pre-clinical medicine with special interests in neurobiology (the hippocampus and hormonal influence on neurogenesis). He was awarded his BA at Cambridge with First Class Honours in 2002. He continued his clinical study at the University of Cambridge Clinical School and qualified in clinical medicine (MB BChir) in 2004. Dr Chai subsequently completed his post-graduate general medical training in London, rotated between St Bartholomew's, London Chest, and the Royal London Hospitals, before embarking on Cardiology specialist training in St Georges Hospital and King's College Hospital in London. He was awarded the prestigious Medical Research Council Clinical Research Fellowship to pursue his doctoral research in cardiovascular imaging and vascular biology, and was awarded his PhD / DPhil in Cardiovascular Medicine at the University of Oxford in 2016. His research focused on the translational aspect using a novel clinically useful non-invasive MRI technique in characterising fatty deposits in the arteries (atherosclerotic plaque) in particular their lipid composition, which was then correlated to the functional heterogeneity of plaque inflammatory cells (macrophages) using gene expression microarray technology. This novel platform of plaque characterisation showed early promise in facilitating future efforts in patient stratification for more individualised aggressive treatment against atherosclerotic disease. His award-winning research had been presented at many international conferences and published in many peer-reviewed journals.

Dr Chai specialises in complex coronary intervention including chronic total occlusions. He also has a specialist interest in the treatment of dyslipidaemia in the context of atherosclerotic disease.